A functional monoclonal antibody recognizing the human alpha 1-integrin I-domain

Area of Science:

• Cell biology
• Immunology
• Molecular biology

Background:

• The alpha 1 beta 1 heterodimer is an integrin receptor involved in cell-matrix interactions.
• Integrins mediate cell adhesion to extracellular matrix components like collagen and fibronectin.
• The alpha 1 integrin contains an I-domain, a feature shared with other integrins such as alpha M, alpha L, alpha X, and alpha 2.

Purpose of the Study:

• To characterize a novel monoclonal antibody (mAb), FB12, targeting the human alpha 1 I-domain.
• To investigate the role of the alpha 1 I-domain in lymphocyte adhesion to extracellular matrix proteins.
• To explore the potential involvement of alpha 1 integrin in tumor biology.

Main Methods:

• Development and characterization of an anti-alpha 1 I-domain specific monoclonal antibody (mAb) FB12.
• Binding assays using human and rat recombinant I-domain GST fusion proteins to assess antibody specificity.
• Inhibition assays to evaluate the effect of FB12 mAb on activated human lymphocyte adhesion to laminin, collagen, and fibronectin.

Main Results:

• The FB12 mAb specifically recognizes an epitope within the human alpha 1 I-domain and does not bind to the rat equivalent.
• FB12 mAb effectively inhibits the binding of activated human lymphocytes to laminin, collagen, and fibronectin.
• Lymphocyte adhesion to fibronectin mediated by alpha 1 integrin is dependent on the I-domain, distinct from RGD-dependent adhesion.

Conclusions:

• The alpha 1 I-domain plays a crucial role in alpha 1 beta 1 integrin-mediated receptor-ligand binding.
• Alpha 1 integrin-dependent lymphocyte adhesion to fibronectin is mediated by the I-domain.
• Overexpression of alpha 1 integrin in tumor stromal cells and blood vessels suggests its potential involvement in tumor progression.